Europe PMCopen access
Subcutaneous drug delivery of high concentration antibody products - part 2: formulation, device options, and clinical bridging strategies for patient-centric commercial presentations
Tolerance, Pharmacokinetics, Monoclonal antibody, Hyaluronidase, Biopharmaceutics, Biologics
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 273470
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.